ara290 cibinetide (MedChemExpress)
Structured Review

Ara290 Cibinetide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-p0168/Cibinetide/pmc10941562-33-0-5
Average 93 stars, based on 7 article reviews
Images
1) Product Images from "Erythropoietin‐derived peptide ARA290 mediates brain tissue protection through the β‐common receptor in mice with cerebral ischemic stroke"
Article Title: Erythropoietin‐derived peptide ARA290 mediates brain tissue protection through the β‐common receptor in mice with cerebral ischemic stroke
Journal: CNS Neuroscience & Therapeutics
doi: 10.1111/cns.14676
Figure Legend Snippet: ARA290 exerts a similar neuroprotective effect as erythropoietin (EPO) in cerebral ischemic mice. (A) Representative coronal sections stained with 2, 3, 5‐triphenyl‐tetrazolium chloride (TTC), showing the size of the infarction volume; (B) Schematic diagram of the percentage of brain infarction in different groups at 7 days after middle cerebral artery occlusion (MCAO). ARA290 was injected intraperitoneally (i.p.) at the beginning of reperfusion after the MCAO surgery. 30, qd: administered with ARA290 at doses of 30 μg/kg once daily; 30, bid: administered with ARA290 at doses of 30 μg/kg twice daily; 100, qd: administered with ARA290 at doses of 100 μg/kg once daily. Data are presented as mean ± SEM, n = 8–9 per group. ** p < 0.01, 30 bid group vs. MCAO group. (C) Representative coronal sections stained with TTC, and (D) a schematic diagram illustrating the percentage of brain infarction in different groups at 7 days after MCAO. Data are presented as mean ± SEM, n = 5–6 per group. * p < 0.05, EPO group vs. MCAO group; *** p < 0.001, ARA290 group vs. MCAO group. (E) Representative coronal sections and (F) a schematic diagram of the percentage of brain tissue loss in the different groups 14 days after MCAO. Data are presented as mean ± SEM, n = 6–7 per group. * p < 0.05, EPO group vs. MCAO group; * p < 0.05, ARA290 group vs. MCAO group. (G) Body weight in different groups after MCAO. (H, I) Longa test and modified neurological severity scores were evaluated in different groups. Data are presented as mean ± SEM, n = 9–10 per group. *** p < 0.001, EPO group vs. MCAO group; ** p < 0.01, ARA290 group vs. MCAO group; *** p < 0.001, ARA290 group vs. MCAO group.
Techniques Used: Staining, Injection, Modification
Figure Legend Snippet: ARA290 attenuates neuronal apoptosis and inflammation in the per‐infarct region after cerebral ischemia. (A) Photomicrographs displaying terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) (red) and NeuN (green) double‐positive cells in the peripheral area of brain infarction in different groups 7 days after middle cerebral artery occlusion (MCAO). DAPI (blue) indicates the cell nuclei. Scale bar, 50 μm. (B) Quantification of TUNEL + /NeuN + colabeling cells in different groups. Data are presented as mean ± SEM, n = 6 per group. * p < 0.05, ARA290 group vs. MCAO group. The quantification of TNF‐α (C), IL‐1β (D), and IL‐6 (E) expression in the Sham, MCAO, and ARA290 treatment mouse brain at 1 and 7 days post‐MCAO. Data are presented as mean ± SEM, n = 4–9 per group. *** p < 0.001, MCAO group vs. Sham group; # p < 0.05, ## p < 0.01, ### p < 0.001, ARA290 group vs. MCAO group.
Techniques Used: TUNEL Assay, Expressing
Figure Legend Snippet: ARA290 produces a metabolomic signature in middle cerebral artery occlusion (MCAO) mice. (A) Principal Component Analysis (PCA) scores among the Sham, MCAO, and ARA290 groups. (B) Volcano plots display all metabolite alterations in the plasma of mice between groups. (C) Metabolic pathway enrichment analysis of differential metabolites in the plasma of mice, n = 5 per group. All matched pathways are displayed as circles; the colors of the circles are based on the pathways' p ‐value, and the size is based on the impact value. Redder and larger circles indicate lower p ‐values and greater count numbers.
Techniques Used:
Figure Legend Snippet: ARA290 abolishes the erythropoietic activity of erythropoietin (EPO) without potential safety issues. (A) Respective representative photographs of spleens from different groups 7 days after middle cerebral artery occlusion (MCAO) surgery. Histograms showing the spleen's weight (B) and length (C) in different groups. Data are presented as mean ± SEM, n = 5–7 per group. * p < 0.05, ** p < 0.01, MCAO group vs. Sham group; ** p < 0.05, EPO group vs. Sham group; ### p < 0.001, EPO group vs. MCAO group; +++ p < 0.001, ARA290 group vs. EPO group. Quantification of the blood parameters of RBC (D), HGB (E), PLT (F), HCT (G), RDW‐CV (H), RDW‐SD (I), and MCV (J) from different groups 7 days after MCAO surgery. Data are presented as mean ± SEM, n = 5 per group. * p < 0.05, ** p < 0.01, *** p < 0.001, EPO group vs. Sham group; ## p < 0.01, ### p < 0.001, ARA290 group vs. EPO group. HCT, hematocrit; HGB, hemoglobin; MCV, mean corpuscular volume; PLT, platelet; RBC, red blood cell; RDW‐CV, coefficient variation of red blood cell volume distribution width; RDW‐SD, standard deviation in red cell distribution width. (K–M) The serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) levels were determined by commercial reagent kits 14 days after MCAO surgery. Data are presented as mean ± SEM, n = 8–9 per group.
Techniques Used: Activity Assay, Standard Deviation
Figure Legend Snippet: β‐Common receptor (βCR) is essential in the neuroprotective effect of ARA290 against cerebral ischemic stroke. (A) Western blot analysis shows the efficiency of βCR siRNA on the expression of βCR in brain tissue 1 day after middle cerebral artery occlusion (MCAO) surgery. β‐Actin was used as a control to normalize protein expression. Data are presented as mean ± SEM, n = 4 per group. *** p < 0.001, MCAO + βCR siRNA group vs. MCAO + negative control (NC) group. (B) Representative coronal sections stained with 2, 3, 5‐triphenyltetrazolium chloride (TTC) and (C) a schematic diagram of the percentage of brain infarction in the different groups 7 days after MCAO. Data are presented as mean ± SEM, n = 8 per group. * p < 0.05, ARA290 + NC group vs. MCAO + NC group; # p < 0.05, ARA290 + βCR siRNA group vs. ARA290 + NC group. (D) Representative coronal sections and (E) schematic diagram of the percentage of brain tissue loss in the different groups 14 days after MCAO. Data are presented as mean ± SEM, n = 4–5 per group. * p < 0.05, erythropoietin (EPO) + NC group vs. MCAO + NC group.
Techniques Used: Western Blot, Expressing, Control, Negative Control, Staining
Related Articles
Control:Article Title: EPOR activation attenuates colitis via enhancing LC3B-dependent apoptotic cell clearance. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 82071209; Jiangsu Provincial Key Research and Development Program, Grant/Award Number: BE2022673 Abstract Systemic immune activation and excessive inflammatory response, induced by intestinal barrier damage, are the major characteristics of inflammatory bowel disease (IBD).. Excessive apoptotic cell accumulation leads to the production of a large number of inflammatory factors, further aggravating IBD development.. Gene set enrichment analysis data showed that the homodimeric erythropoietin receptor (EPOR) was highly expressed in the whole blood of patients with IBD. Incubation:Article Title: EPOR activation attenuates colitis via enhancing LC3B-dependent apoptotic cell clearance. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 82071209; Jiangsu Provincial Key Research and Development Program, Grant/Award Number: BE2022673 Abstract Systemic immune activation and excessive inflammatory response, induced by intestinal barrier damage, are the major characteristics of inflammatory bowel disease (IBD).. Excessive apoptotic cell accumulation leads to the production of a large number of inflammatory factors, further aggravating IBD development.. Gene set enrichment analysis data showed that the homodimeric erythropoietin receptor (EPOR) was highly expressed in the whole blood of patients with IBD. Cell Culture:Article Title: EPOR activation attenuates colitis via enhancing LC3B-dependent apoptotic cell clearance. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 82071209; Jiangsu Provincial Key Research and Development Program, Grant/Award Number: BE2022673 Abstract Systemic immune activation and excessive inflammatory response, induced by intestinal barrier damage, are the major characteristics of inflammatory bowel disease (IBD).. Excessive apoptotic cell accumulation leads to the production of a large number of inflammatory factors, further aggravating IBD development.. Gene set enrichment analysis data showed that the homodimeric erythropoietin receptor (EPOR) was highly expressed in the whole blood of patients with IBD. Injection:Article Title: The Role of Macrophage Efferocytosis in the Pathogenesis of Apical Periodontitis Article Snippet: .. Following the pulp operation, other:Article Title: ARA290 Attenuates Apical Periodontitis via SIRT1/NF-κB/IL-1β Pathway Modulation Article Snippet: Upon reaching 70% confluence, a dose of 100 ng/ml E. coli LPS (Sigma) was administered to the RAW264.7 cells for 24 hours to establish the AP in vitro model. |
